226 related articles for article (PubMed ID: 30486290)
1. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells.
Moon JY; Manh Hung LV; Unno T; Cho SK
Nutrients; 2018 Nov; 10(12):. PubMed ID: 30486290
[TBL] [Abstract][Full Text] [Related]
2. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
Hung LVM; Moon JY; Ryu JY; Cho SK
Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line.
Manh Hung LV; Song YW; Cho SK
Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29584673
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from Citrus depressa on non-small-cell lung cancer cell lines.
Uesato S; Yamashita H; Maeda R; Hirata Y; Yamamoto M; Matsue S; Nagaoka Y; Shibano M; Taniguchi M; Baba K; Ju-ichi M
Planta Med; 2014 Apr; 80(6):452-7. PubMed ID: 24687742
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer.
Wan J; Ling XA; Wang J; Ding GG; Wang X
J Cell Mol Med; 2020 Nov; 24(21):12840-12847. PubMed ID: 32945069
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
7. Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway.
Jagadeeshan S; David D; Jisha S; Manjula S; Asha Nair S
BMC Complement Altern Med; 2017 Jul; 17(1):370. PubMed ID: 28720093
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
9. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr].
Zhao C; Zheng XL; Yan YY; Song H; Li DX; Yang L; Qin Y; Lin Y; Wang X; Liao LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):893-7. PubMed ID: 25571710
[TBL] [Abstract][Full Text] [Related]
10. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
12. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells.
Magesh V; Lee JC; Ahn KS; Lee HJ; Lee HJ; Lee EO; Shim BS; Jung HJ; Kim JS; Kim DK; Choi SH; Ahn KS; Kim SH
Phytother Res; 2009 Oct; 23(10):1385-91. PubMed ID: 19277950
[TBL] [Abstract][Full Text] [Related]
13. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.
Yao J; Wei X; Lu Y
Biochem Biophys Res Commun; 2016 May; 473(4):867-873. PubMed ID: 27038543
[TBL] [Abstract][Full Text] [Related]
14. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
15. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.
Yu J; Chen WX; Xie WJ; Chen RW; Lin DQ; You WW; Ye WL; Zhang HQ; Lin DH; Xu JP
J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells.
Jiang YP; Guo H; Wang XB
Biomed Pharmacother; 2018 Jul; 103():29-37. PubMed ID: 29635125
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
18. Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways.
Pan CH; Chen SY; Wang JY; Tsao SP; Huang HY; Wei-Chen Chiu P; Wu CH
Chem Biol Interact; 2020 Dec; 332():109304. PubMed ID: 33164868
[TBL] [Abstract][Full Text] [Related]
19. PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells.
Zhao XM; Pan SY; Huang QL; Lu YN; Wu XH; Chang JH; Liu ZB; Cai XW; Liu Q; Wang JL; Fu XL
Oncotarget; 2016 Aug; 7(31):49384-49396. PubMed ID: 27283902
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.
Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P
Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
